Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2159
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorKERR, Daniel Shikanai-
dc.contributor.authorTALIB, Leda Leme-
dc.contributor.authorYAMAMOTO, Victor Junji-
dc.contributor.authorFERREIRA, Aline S.-
dc.contributor.authorZANETTI, Marcus V.-
dc.contributor.authorSERPA, Mauricio H.-
dc.contributor.authorBUSATTO, Geraldo F.-
dc.contributor.authorBILT, Martinus Theodorus Van de-
dc.contributor.authorGATTAZ, Wagner Farid-
dc.date.accessioned2013-09-23T16:44:15Z-
dc.date.available2013-09-23T16:44:15Z-
dc.date.issued2013-
dc.identifier.citationSCHIZOPHRENIA RESEARCH, v.147, n.1, p.203-204, 2013-
dc.identifier.issn0920-9964-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2159-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE BV-
dc.relation.ispartofSchizophrenia Research-
dc.rightsrestrictedAccess-
dc.subject.otherphospholipase a(2) enzymes-
dc.titleAntipsychotic drugs decrease iPLA(2) gene expression in schizophrenia-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE BV-
dc.identifier.doi10.1016/j.schres.2013.03.026-
dc.identifier.pmid23587695-
dc.subject.wosPsychiatry-
dc.type.categoryletter-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage203-
hcfmusp.description.endpage204-
hcfmusp.description.issue1-
hcfmusp.description.volume147-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84877108068-
hcfmusp.origem.idWOS:000319047100032-
hcfmusp.publisher.cityAMSTERDAM-
hcfmusp.publisher.countryNETHERLANDS-
hcfmusp.relation.referenceDennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w-
hcfmusp.relation.referenceGattaz WF, 2011, J PSYCHIATR RES, V45, P1617, DOI 10.1016/j.jpsychires.2011.07.005-
hcfmusp.relation.referenceGATTAZ WF, 1987, BIOL PSYCHIAT, V22, P421, DOI 10.1016/0006-3223(87)90164-8-
hcfmusp.relation.referenceGreen JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200-
hcfmusp.relation.referenceKudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5-
hcfmusp.relation.referencePfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45-
hcfmusp.relation.referenceRoss BM, 2006, BIPOLAR DISORD, V8, P265, DOI 10.1111/j.1399-5618.2006.00299.x-
hcfmusp.relation.referenceVandesompele J., 2002, GENOME BIOL, V3-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus7-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPS
Departamento de Psiquiatria - FM/MPS

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - LIM/21
LIM/21 - Laboratório de Neuroimagem em Psiquiatria

Artigos e Materiais de Revistas Científicas - LIM/27
LIM/27 - Laboratório de Neurociências


Files in This Item:
File Description SizeFormat 
art_KERR_Antipsychotic_drugs_decrease_iPLA(2)_gene_expression_in_schizophrenia_2013.PDF
  Restricted Access
publishedVersion (English)117.78 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.